BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21133730)

  • 1. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
    Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
    Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.
    Hancer VS; Diz-Kucukkaya R; Aktan M
    Med Oncol; 2012 Jun; 29(2):1068-72. PubMed ID: 21264533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.
    Heintel D; Kroemer E; Kienle D; Schwarzinger I; Gleiss A; Schwarzmeier J; Marculescu R; Le T; Mannhalter C; Gaiger A; Stilgenbauer S; Döhner H; Fonatsch C; Jäger U;
    Leukemia; 2004 Apr; 18(4):756-62. PubMed ID: 14961036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia.
    Gelmez MY; Coskunpinar E; Saracoglu B; Deniz G; Aktan M
    Immunol Invest; 2017 Jul; 46(5):433-446. PubMed ID: 28388279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
    Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
    Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status.
    Gelmez MY; Teker AB; Aday AD; Yavuz AS; Soysal T; Deniz G; Aktan M
    Leuk Lymphoma; 2014 Feb; 55(2):326-30. PubMed ID: 23662991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.
    Albesiano E; Messmer BT; Damle RN; Allen SL; Rai KR; Chiorazzi N
    Blood; 2003 Nov; 102(9):3333-9. PubMed ID: 12855567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of puma mRNA levels by real-time quantitative RT-PCR in chronic lymphocytic leukemia and its clinical significance].
    Zhu HJ; Xu W; Cao X; Fang C; Zhu DX; Dong HJ; Wang DM; Qiao C; Miao KR; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):843-8. PubMed ID: 20723285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.
    Patten PE; Chu CC; Albesiano E; Damle RN; Yan XJ; Kim D; Zhang L; Magli AR; Barrientos J; Kolitz JE; Allen SL; Rai KR; Roa S; Mongini PK; MacCarthy T; Scharff MD; Chiorazzi N
    Blood; 2012 Dec; 120(24):4802-11. PubMed ID: 23071276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
    Palacios F; Moreno P; Morande P; Abreu C; Correa A; Porro V; Landoni AI; Gabus R; Giordano M; Dighiero G; Pritsch O; Oppezzo P
    Blood; 2010 Jun; 115(22):4488-96. PubMed ID: 20233972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.
    McCarthy H; Wierda WG; Barron LL; Cromwell CC; Wang J; Coombes KR; Rangel R; Elenitoba-Johnson KS; Keating MJ; Abruzzo LV
    Blood; 2003 Jun; 101(12):4903-8. PubMed ID: 12586616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
    Grund S; Olsson B; Jernås M; Jacobsson S; Swolin B; Nabi IR; Carlsson L; Wadenvik H
    Med Oncol; 2011 Dec; 28(4):1542-8. PubMed ID: 20574759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
    PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia.
    Jasek M; Bojarska-Junak A; Wagner M; Sobczyński M; Wołowiec D; Roliński J; Karabon L; Kuśnierczyk P
    Tumour Biol; 2016 Oct; 37(10):13617-13626. PubMed ID: 27468724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
    Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
    Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.